Nicorette
Nicorette is a branded over-the-counter palliative treatment which is used to ameliorate the withdrawal effects involved in quitting smoking. It was part of Pfizer Consumer Healthcare Products Company, which was sold to Johnson & Johnson in 2006. Originally available as a patch for topical application, it was later made available as a nicotine gum (composed of nicotine polacrilex) lozenge, inhaler, and nasal spray. All these products contain nicotine as the active ingredient and work by delivering this into the bloodstream. These treatments are commonly referred to as nicotine replacement therapies.
Alternative brand names include Prostep, Habitrol, Nicotrol, Nicoderm, and Commit.
Commit lozenges are an oral palliative aid in the cessation of smoking. Formats of both 4 mg (for those who smoke their first daily cigarette within 30 minutes of waking) and 2 mg (for those who wait more than 30 minutes before the first daily dose of nicotine), are available. The lozenges, which are of a minty flavour, are meant to be taken orally at least nine times a day during the first two weeks after a nicotine user is willing to quit using tobacco products.
Nicorette inhalers are widely available over the counter. In the United States they are branded as Nictrol Inhalers and are only available on prescription.
It is encouraged that you should stop using Nicorette after 12 weeks. This product can become addictive just like smoking if abused. An internet search can find many overseas or Canadian retailers shipping to the USA for half price.
Gum Flavors
External links
Template:Treatment-stub sv:Nicorette Template:WikiDoc Sources